MARIKATE HOWE: Open Payments
NPI 1093242810 · BRANDON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,234 in 185 payments from 43 companies in 2025. Trend: 2023 $1,999 · 2024 $3,985 · 2025 $4,234
Food & beverage: $4,222Education: $12
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 26 | $470 |
| Incyte Corporation | 10 | $346 |
| ABBVIE INC. | 12 | $322 |
| E.R. Squibb & Sons, L.L.C. | 16 | $302 |
| Gilead Sciences, Inc. | 12 | $266 |
| PFIZER INC. | 12 | $257 |
| Merck Sharp & Dohme LLC | 9 | $216 |
| AstraZeneca Pharmaceuticals LP | 8 | $155 |
| Celgene Corporation | 7 | $152 |
| Janssen Biotech, Inc. | 6 | $141 |
Products named: Trodelvy, OPDIVO, JAKAFI, KISQALI, KEYTRUDA, TEVIMBRA, Fabhalta, REBLOZYL.
Industry payments across FL — which companies pay providers there.
